Maeve is partner in the Corporate and M&A Group. Maeve advises on public and private mergers and acquisitions, joint ventures, private equity investments, equity capital markets and corporate reorganisations.

Maeve advises on both domestic and cross border transactions across various industries.

Maeve was previously based in the London and New York offices of Arthur Cox and also advises international clients on inward investment and corporate governance matters.

Relevant Experience

  • Advising a search fund led by Mission Spring Ventures and Pacific Lake Partners on its acquisition of ETU, a leading immersive and simulation based learning provider
  • Advising Glanbia plc on the disposal of its 40% interest in Glanbia Ireland DAC to Glanbia Co-operative Society Limited
  • Advising InfraVia Capital Partners on its investment of a 49.9% stake in Fibre Networks Ireland Holdings Limited, a dedicated joint venture fibre company with eir focused on the deployment of fibre-to-the-home across the Republic of Ireland
  • Advising Total Produce plc on its combination with Dole Food Company, Inc. and the successful IPO of Dole plc
  • Advising Greenergy International Limited on its acquisitions in Ireland, including Inver Energy Limited and Amber Oil
  • Advising Novozymes A/S on its acquisition of PrecisionBiotics
  • Advising Allergan plc on its $63 billion merger with AbbVie
  • Advising AIB Group plc and First Data Corporation on their joint acquisition of 95.9% of the issued share capital of Semeral Limited, the parent company of the Payzone Group
  • Advising Mastercard International Incorporated on all Irish law aspects of its acquisition of Ethoca Limited
  • Advising Brookfield Asset Management on its majority stake investment in the Imagine Communications Group
  • Advising CapVest Partners on its disposal of the Mater Private Hospital to InfraVia Capital Partners
  • Advising Oaktree Capital on the acquisition of The Square, Tallaght
  • Advising Fyffes plc on its EUR750 million acquisition by Sumitomo Corporation
  • Advising Allergan plc on its USD 40billion disposal of its global generic business to Teva Pharmaceuticals


“Maeve Moran is extremely competent, thorough, polished and we felt well represented as a client.”

IFLR 1000: The Guide to the World’s Leading Financial Law Firms, 2022 

“Maeve Moran is a rising star. She has an exceptional grasp of all the SPA mechanics and value levers in getting the deal done and has a unique corporate financier brain wrapped up with what you would expect from an experienced corporate lawyer.”

The Legal 500: Europe, Middle East & Africa, 2020

Maeve Moran is an “excellent lawyer who negotiated various complex and highly emotive matters in a highly regulated business with multiple jurisdictional stakeholders. Commercial and pragmatic at all times, and quality oversight, advice and stewardship of the deal on matters way beyond legal in substance.”

IFLR 1000: The Guide to the World’s Leading Financial Law Firms, 2020

Education & Qualifications

  • Postgraduate Diploma in Arbitration, 2010, University College Dublin
  • BBLS, 2005, University College Dublin
  • Admitted as a solicitor in England & Wales, 2012 (non-practising)
  • Admitted as a solicitor in Ireland, 2010
  • Member of Law Society of Ireland
  • Member of Law Society of England & Wales